Identification of urinary protein pattern in Type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis

Journal of Diabetes and its Complications

Volumn 19, Issue 4, 2005, Pages 223-232

  Meier, Matthias ^a   Kaiser, Thorsten ^b   Herrmann, Alena ^a   Knueppel, Stefan ^a   Hillmann, Meike ^b   Koester, Peer ^b   Danne, Thomas ^c   Haller, Hermann ^a   Fliser, Danilo ^a   Mischak, Harald ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^c Children Hospital Bult   (Germany)

Author keywords

Capillary electrophoresis; Diabetic nephropathy; Mass spectrometry; Microalbuminuria; Urinary proteomics

Indexed keywords

ALBUMIN; CREATININE; POLYPEPTIDE; PROTEIN; PROTEOME;

ADOLESCENT; ARTICLE; CAPILLARY ELECTROPHORESIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MASS SPECTROMETRY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEOMICS; URINALYSIS;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROTEINURIA; PROTEOME; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 21344467291     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2004.10.002     Document Type: Article

References (39)

1. A.R. Andersen, J.S. Christiansen, J.K. Andersen, S. Kreiner, and T. Deckert Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study Diabetologia 25 1983 496 501
2. S. Araki, D.P. Ng, B. Krolewski, L. Wyrwicz, J.J. Rogus, L. Canani, Y. Makita, M. Haneda, J.H. Warram, and A.S. Krolewski Identification of a Common Risk Haplotype for Diabetic Nephropathy at the Protein Kinase C-beta1 (PRKCB1) Gene Locus Journal of the American Society of Nephrology 14 2003 2015 2024
3. H.J. Bangstad, R. Osterby, S. Rudberg, A. Hartmann, K. Braband, and K.F. Hansen Kidney function and glomerulopathy over 8 years in young patients with Type 1 (insulin-dependent) diabetes mellitus and microalbuminuria Diabetologia 45 2002 253 261
4. A. Bohle, M. Wehrmann, O. Bogenschutz, C. Batz, C.A. Muller, and G.A. Muller The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis Pathology, Research and Practice 187 1991 251 259
5. M. Bojestig, H.J. Arnqvist, G. Hermansson, B.E. Karlberg, and J. Ludvigsson Declining incidence of nephropathy in insulin-dependent diabetes mellitus New England Journal of Medicine 330 1984 15 18
6. K. Borch-Johnsen Improving prognosis of type 1 diabetes. Mortality, accidents, and impact on insurance Diabetes Care 2 Suppl. 22 1999 B1 B3
7. M.L. Caramori, P. Fioretto, and M. Mauer The need for early predictors of diabetic nephropathy risk. Is albumin excretion rate sufficient? Diabetes 49 2000 1399 1408
8. Conquering Diabetes: A Report of the Congressionally-Established Diabetes Research Working Group 1999 (NIH publ. No. 99-43). Bethesda, MD: National Diabetes Information Clearinghouse.
9. G. D'Amico, and C. Bazzi Pathophysiology of proteinuria Kidney International 63 2003 809 825
10. M.T. Davis, C.S. Spahr, M.D. McGinley, J.H. Robinson, E.J. Bures, J. Beierle, J. Mort, W. Yu, R. Luethy, and S.D. Patterson Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry: II. Limitations of complex mixture analyses Proteomics 1 2001 108 117
11. P. Gaede, P. Vedel, H.H. Parving, and O. Pedersen Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno Type 2 Randomised Study Lancet 353 1999 617 622
12. D. Gorman, E. Sochett, and D. Danemann The natural history of microalbuminuria in adolescents with type 1 diabetes Journal of Pediatrics 134 1999 333 337
13. D.J. Hampel, C. Sansome, M. Sha, S. Brodsky, W.E. Lawson, and M.S. Goligorsky Toward proteomics in uroscopy: Urinary protein profiles after radiocontrast medium administration Journal of the American Society of Nephrology 12 2001 1026 1035
14. Heart Outcomes Prevention Evaluation Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy Lancet 355 2000 253 259
15. D.F. Hochstrasser, J.C. Sanchez, and R.D. Appel Proteomics and its trends facing nature's complexity Proteomics 2 2002 807 812
16. C.Y. Hong, and K.S. Chia Markers of diabetic nephropathy Journal of Diabetes and Its Complications 12 1998 43 60
17. T. Kaiser, A. Hermann, J.T. Kielstein, S. Wittke, S. Bartel, R. Krebs, F. Hausadel, M. Hillmann, I. Golovko, P. Koester, H. Haller, E.M. Weissinger, D. Fliser, and H. Mischak Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids Journal of Chromatography, A 1013 2003 157 171
18. S. Kennedy Proteomic profiling from human samples: The body fluid alternative Toxicology Letters 120 2001 379 384
19. M.A. Knepper Proteomics and the kidney Journal of the American Society of Nephrology 13 2002 1398 1408
20. A.S. Krolewski, D.P. Ng, L.H. Canani, and J.H. Warram Genetics of diabetic nephropathy: How far are we from finding susceptibility genes? Advances in Nephrology from the Necker Hospital 31 2001 295 315
21. A. Lapolla, D. Fedele, and P. Traldi Diabetes and mass spectrometry Diabetes Metabolism Research and Reviews 17 2001 99 112
22. M. Mann, R.C. Hendrickson, and A. Pandey Analysis of proteins and proteomes by mass spectrometry Annual Review of Biochemistry 70 2001 437 473
23. T. Marshall, and K.M. Williams Clinical analysis of human urinary proteins using high resolution electrophoretic methods Electrophoresis 19 1998 1752 1770
24. S.M. Mauer, M.W. Steffes, E.N. Ellis, D.E. Sutherland, D.M. Brown, and F.C. Goetz Structural-functional relationships in diabetic nephropathy Journal of Clinical Investigations 74 1984 1143 1155
25. C.E. Mogensen Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes New England Journal of Medicine 310 1984 356 360
26. C.E. Mogensen, C.K. Christensen, and E. Vittinghus The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy Diabetes 2 Suppl. 32 1983 64 78
27. H.H. Parving, N. Chaturvedi, G. Viberti, and C.E. Mogensen Does microalbuminuria predict diabetic nephropathy? Diabetes Care 25 2002 406 407
28. B.A. Perkins, L.H. Ficociello, K.H. Silva, D.M. Finkelstein, J.H. Warram, and A.S. Krolewski Regression of microalbuminuria in type 1 diabetes New England Journal of Medicine 348 2003 2285 2293
29. A.O. Phillips, and R. Steadman Diabetic nephropathy: The central role of renal proximal tubular cells in tubulointerstitial injury Histology and Histopathology 17 2002 247 252
30. E. Ritz Albuminuria and vascular damage-The vicious twins New England Journal of Medicine 348 2003 2349 2352
31. R.A. Rodby, R.D. Rohde, Z. Sharon, M.A. Pohl, R.P. Bain, E.J. Lewis The Collaborative Study Group The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy American Journal of Kidney Diseases 26 1995 904 909
32. C.J. Schultz, T. Konopelska-Bahu, R.N. Dalton, T.A. Carroll, I. Stratton, E.A. Gale, A. Neil, D.B. Dunger Oxford Regional Prospective Study Group Microalbuminuria prevalence varies, with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study Diabetes Care 22 1999 495 502
33. J. Schultz, H.A. Neil, R.N. Dalton, D.B. Dunger Oxford Regional Prospective Study Group Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes Diabetes Care 23 2000 1811 1815
34. C.S. Spahr, M.T. Davis, M.D. McGinley, J.H. Robinson, E.J. Bures, J. Beierle, J. Mort, P.L. Courchesne, K. Chen, R.C. Wahl, W. Yu, R. Luethy, and S.D. Patterson Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry: I. Profiling an unfractionated tryptic digest Proteomics 1 2001 93 107
35. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy New England Journal of Medicine 342 2000 381 389
36. The EUCLID Study Group Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria Lancet 349 1997 1787 1792
37. P.J. Thornalley, M. Argirova, N. Ahmed, V.M. Mann, O. Argirov, and A. Dawnay Mass spectrometric monitoring of albumin in uremia Kidney International 58 2000 2228 2234
38. E.M. Weissinger, S. Wittke, T. Kaiser, H. Haller, S. Bartel, R. Krebs, I. Golovko, H.D. Rupprecht, M. Haubitz, H. Hecker, H. Mischak, and D. Fliser Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes Kidney International 65 2004 2426 2434
39. S. Wittke, D. Fliser, M. Haubitz, S. Bartel, R. Krebs, F. Hausadel, M. Hillmann, I. Golovko, P. Koester, H. Haller, T. Kaiser, H. Mischak, and E.M. Weissinger Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers Journal of Chromatography, A 1013 2003 173 181